NOC

Northrop Grumman (NOC) Issues Debt to Fund Share Buybacks

Northrop Grumman Corporation has priced a $2.5 billion underwritten public offering of senior unsecured notes. The offering includes $500 million of 4.600% senior notes due 2029, $850 million of 4.900% senior notes due 2034, and $1.15 billion of 5.200% senior notes due 2054. The company expects to use the net proceeds for general corporate purposes, including debt repayment, share repurchases, and working capital. The offering is anticipated to close on January 31, 2024.

Vic Beck, Northrop Grumman's media contact, stated, "This offering will provide us with the financial flexibility to support our business objectives and enhance shareholder value."

Todd Ernst, the company's investor contact, added, "We believe this offering demonstrates our commitment to maintaining a strong financial position and capital structure while continuing to invest in our business for the long term."

Northrop Grumman Corporation, a leading global aerospace and defense technology company, is focused on equipping its customers with the capabilities they need to connect and protect the world. The company's shares have moved 0.6%, and are now trading at a price of $440.94.

The company's full 8-K submission is available here.

2018 2019 2020 2021 2022 2023
Revenue (MM) $30,095 $33,841 $36,799 $35,667 $36,602 $38,685
Revenue Growth n/a 12.45% 8.74% -3.08% 2.62% 5.69%
Operating Margins 13% 12% 11% 16% 10% 10%
Net Margins 11% 7% 9% 20% 13% 12%
Net Income (MM) $3,229 $2,248 $3,189 $7,005 $4,896 $4,671
Net Interest Expense (MM) $562 $528 $593 $556 $506 $537
Earnings Per Share $18.49 $13.22 $19.03 $43.54 $31.47 $30.44
EPS Growth n/a -28.5% 43.95% 128.8% -27.72% -3.27%
Diluted Shares (MM) 173 168 167 161 156 152
Free Cash Flow (MM) $2,578 $3,033 $2,885 $2,152 $1,466 $2,092
Capital Expenditures (MM) $1,249 $1,264 $1,420 $1,415 $1,435 $1,604
Current Ratio 1.17 1.13 1.6 1.3 1.08 1.28
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS